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•9"d'• Enalapdl (EN) Improves Alveolar-Capillary 
Diffusion In Chronic Heart Failure (CHF) and 
Aspirin (AS) Contrasts This Effect 
Marco Guazzi, Pier G. Agestonl, Gian C. Marenzi, Gian R Laud, 
Emilio Assanelli, Maudzio D. Ouazzi. University of Milan, M#an, italy 
Prestaglaedins (PGs) participate in the local control of transcapillary fluid flux 
and interstitial volume. ACE is concentrated in the lung vessels and ACE- 
inhibitors expose them to enhanced formation of PGs. Were PGs involved 
in the regulation of extravascular lung fluid, ACE inhibitors and AS would 
probably exert an opposite therapeutic action in CHF, where lung fluid plays 
a pivotal role. To probe this assumption 15 CHF patients (111, NYHA), treated 
with digoxin and furosemide, received {random and double-blind) placebo 
(PL), EN (20 rag), AS (325 rag), EN + AS, for 15 days each. Vitol capacity 
(VC), maximal voluntary ventilation (MW), lung diffusing capacity (DLCO) 
and oxygen consumption (VO2p), ventilation (VEp), tidal volume, (VTp), dead 
space/tidal volume ratio (VDNT) at peak exercise were tested at the end of 
each step. 
vo2 p VE D ~ p VDNT MW VC DLCO 
PL 15.0 47.9 1.49 0.23 89 3.1 22 
4-5 :1:15 ±0.4 4-0.6 ~24 ~7 4-7 
EN 18.8 64 1.71 0.20 104 3.2 24 
4- 4°~ 4-12 *#§ 4- 0.3"#~ 4- 6*§ 4- 21 * 4- 6 4- 6 °~ 
AS 15.8 50 1.50 0.24 93 3.0 22 
d:4 4-15 4-0.3 4-0.6 4-21 4-7 4-7 
EN + AS 16.7 54.8 1.54 0.22 103 3.1 22 
4-4 4-12 4-0.9 4-0.5 4-24* 4-6 4-7 
Mean~ .4- SD, *p < 0.05 vs PL; §p < 0.05 vs AS; #p < 0.05 vs EN + AS 
Conclusions: a) Changes in DLCO and lung mechanics with EN are con- 
sistent with modulation of lung interstitial f .id, ameliorating respiratory and 
functional capacities; b) PG stimulation seems to undedie these actions as 
they are counteracted by a PG inhibitor. 
C-Myc Expression Relates to Decrease in 
Myocardial Contractility in Patients Wdh Chronio 
Aort ic Rogurgitation 
Satoshi Taketant, Kazuhiro Taniguchl, Yoshikl Saws, Keiji Kedoba, 
Masataka Mitsuno, Hikaru Mstsuda, Shunzo Onishi ~, 
Naomasa Kawaguchi ~ . r 1st Depf of Surg, School of Allied Health Science, 
Osaka Univ., Osaka, Japan 
In patients with end-stage aortic regurgitation (AR), excess of volume-load 
on the left ventricle (LV) cause congestive heart failure associated with a 
decrease in LV contractility. Recently, proto-oncogenes have been implicated 
in the pathogenesis o! myocardial remodeling resulting in a decrease in LV 
contractility. However, in human heart, it has never been clarified whether 
C-Myc may relate to contractile impairment and structural alteration. In the 
present study, the expression of C-Myc in myocardium were examined in 
patients with AR. Nine patients (7 male and 2 female) aged from 31 to 70 
years (mean, 52.9 ± 13,4) with Isolated chronic AR underwent aortic valve 
replacement. Preoperative NYHA class was Ifl in 5 patients and IV in 4. 
Ejection fraction of LV (EF)(49.2 ± 11,6%), end-systolic volume index of LV 
(ESVI)(87,4- 30 ml/m 2) and left ventricular mass index (LVMI)(183 :1: 34 g/n~) 
were measured before surgery. The specimens of LV muscle were obtained 
by endomyocardial biopsy dudng aortic valve replacement. Expression of C- 
Myc were evaluated by Immunohistochemlcat staining. All patients howed 
significant higher values in nw.. ocardial cell diameter (CD)(33.1:1:11.8 p.m)and 
fibrous content (FC)(26.5 + 13.2 g/m ~) than did the non~al control. C- 
Myc(28.3 4- 16,1=/o) was detected in these patients while, it has never been 
detected in normal control. ESVI were inversely correlated with EF(r = 0,94 
p < 0.01), CD (r = 0.93 p < 0.01) and FC(r = 0.95 p < 0.01). C-Myc showed 
inverse correlation with ESVI(r = -0.87 p < 0,05), CD(r == 0.96 p < 0.01) and 
FC(r = 0.92 p < 0.01). These results demonstrated that C-Myo expression 
relate to extensive cellular hypertrophy and interstitial fibrosis and inversely 
relate to ESVI in patients with chronic aortic regurgitation. This suggest hat 
C-My,: may relate to cardiac remodeling, and its dewn-rngulatlon may be 
associated with the decrease in LV contractility. 
~ Differences in Temporal Risk 01 Sudden end 
Nonsudden Death In Patients With End.b~mge 
Heart Failure Listed for  Cardlec Transplantation 
Michael O. Sweeney, John B. Newell, Hasan Garan, Bdan McGovem, Marc 
J. Semigran, Jeremy N. Ruskin. G. William Dec. Massachusetts General 
Hospital, Boston, MA 
Sudden death (SD) is a malor threat to survival in patients with end-stage 
heart failure awaiting cardiac transplentation, Current pdodtizatldn of rectlP 
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lent need for transplantation is based or" critena relating to hemedynamic 
compensation and risk of nonsudden death (NSD). Similar cdteria for strati- 
fying risk of SD do not exist and the temporal pattern of SD risk is unknown. 
We compared actuadal SD and NSD mortality rates in 162 patients listed for 
transplantation using lifetable analysis. There were 43/162 (26.5°/'0) cardiac 
deaths [23(14.2%) sudden and 20(12.3o/=) nonsudden] during mean followup 
15,8 ± 18.3 months. Hazard functions dedved from lifetable analysis were 
plotted as a function of time and the equations of the best-fit lines were 
calculated by linear egression (Figure), 
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The slope of the hazard fur, ction curve expresses the change in (probability 
of death/month per month) independent of censored events (transplantation). 
The SD Slope was positive (+0.03 ± 0.01, R = 0.81, p = 0.04) and the 
NSD slope was negative (-  0.05 ± 0.01, Time (months) after listing R = 
0.92, p = 0.01) consP~ ent with progressively increasing versus progressively 
decreasing rates of change in risk, respectively. 
Condusions: In patients with end-stage heart failure listed and awaiting 
transplantation, the risk of NSD decreases over time, while in contrast, the 
risk of SD increases over time. 
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F9-6~--6"9-] Contribu|ion of  Coronary Vasoconstriction to 
Myocardial Blood Flow Changes Induced by 
Physiologic Stresses 
Asif Rehmen, Anastasia N. Kitsiou, Stephen L Bacharach, Clalbome 
M. Davis, Vasken Dilsizian, Arahed A. Quyyumi. NIH, Bethesda, MD 
Atherosderotic coronary artedes constrict in response to exercise (EX). We 
investigated the impact of coronary vasoconstriction  regional myocardial 
blood flow (MBF) in normal and ischemic zones dudng physiologic stresses 
incluoing bicycle EX. r,'tental stress (MS) using a video game, and compared 
it with adenosine (ADG). Seven men (age 60 -~ 10 years; 5 with 2- and 2 with 
3-vessel CAD} had MBF estimated from N-13 ammonia uptake normalized 
to absolute flow in one sector using PET. All lots had normal eft ventdcu- 
let function (ejection fraction 58 4- 8%) and EX-induced thallium perfusion 
defects. Ischemic segments were defined as regions where ADO.induced 
MBF increase was < 90% of normal segments (supplied by unobstructed 
corenades). MBF changes with EX and MS were compared with ADO in 171 
normal and 101 ischemic segments. (MBF in ml/min/g) 
Rest ADO MS EX 
MBF (Normal zones) 0.82 2.6 1.2 1.7 
MBF (Ischemic zones) 0.75* 1.9"° 1.1 * 1.3" 
*p < 0,05, **p < 0.01 
MBF was lower in ischemio segments at rest, and after MS and EX. De* 
spite development of ischemia (ST depression) dudng EX which would be 
expected to maximize blood flow, MBF in the Iscbemic segments remained 
29% below the level achieved with ADO (that measures flow reserve). SimF 
lady, during MS, MBF in iechemio segments was lower than in normal areas. 
and much lower than ADO, suggesting that coronary vaseconstdction i  is- 
chemic regions occurs dudng both EX and MS. Thus, vaseconstdction of 
coronary stenoses dudng EX and MS causes significant attenuation in MBF 
increases to ischemic regions. Whether these changes can be reversed by 
antiar, gtnal medications needs to be further investigated. 
~-5~ Ro~ ot Bml Coronsry Tone in vesos~=e.= 
Angina 
Yuk(o Ozaki, David Keane, Patrick W. Senuys. Catheterfzat,ion Laboratory, 
Thoraxcanter, Erasmus University Rotterdam, NL 
Previous attempts to determine the vole of' basal coronary tone in the patho- 
physiology of vadant angina have produced conflicting evidence. We ex- 
amined the vasoconstrictor response to ergnnnvine and the vasodilator e- 
sponse to isosorbide dinitrate (basal coronary tone) at spastic and non- 
